The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson's device for treating a heart condition that causes abnormal heart rhythms, the company announced on Thursday.
The device, Varipulse, is a pulsed field ablation system that uses small burns or freezes to create scarring inside the heart, helping to disrupt the electrical signals responsible for irregular heartbeats.
Medical device companies such as Boston Scientific and Medtronic also offer devices approved for treating atrial fibrillation, a condition characterized by irregular heart rhythms.
Click the link BSc Microbiology
The FDA has approved the J&J device for treating drug-refractory paroxysmal atrial fibrillation, a condition where symptoms occur occasionally and typically last from a few minutes to hours.
You may like also
over 6 5 lakh senior citizens have recently joined the ayushman bharat scheme
kea announces ug ayush stray vacancy counselling schedule seat matrix
